BC
BNTX icon

Bridgefront Capital’s BioNTech BNTX Stock Holding History

Bridgefront Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+2,566
New +$241K 0.06% 423
2025
Q4 		– Sell
-3,219
Closed -$317K – 540
2025
Q3 		$317K Buy
3,219
+745
+30% +$79.7K 0.09% 375
2025
Q2 		$263K Buy
+2,474
New +$250K 0.07% 470
2025
Q1 		– Sell
-2,488
Closed -$284K – 633
2024
Q4 		$284K Buy
+2,488
New +$284K 0.1% 376

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Bridgefront Capital's BNTX Position: Q2 2026 in Review

Bridgefront Capital opened a new position in BioNTech (BNTX) in Q2 2026: 2,566 shares worth $239K. The stake represents 0.06% of the portfolio and ranks #423 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in BNTX as recently as Q3 2025.

Bridgefront Capital first reported a position in BNTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $317K in Q3 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Bridgefront Capital held 2,566 shares of BioNTech worth $239K as of Q2 2026.
  • BioNTech was a new Bridgefront Capital position in Q2 2026.
  • BioNTech made up 0.06% of Bridgefront Capital's portfolio in Q2 2026, its #423 holding.
  • Bridgefront Capital first reported a position in BioNTech in Q4 2024 and has held it in 4 quarters since.
  • Bridgefront Capital's BioNTech position peaked at $317K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.